Balaxi Pharmaceuticals Ltd share price logo

Balaxi Pharmaceuticals Ltd

NSE: BALAXI

BSE: 532597

Small Cap

Pharma Sector

₹23.56

+0.11

(+0.47%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Balaxi Pharmaceuticals Stock Performance

as on June 17, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹23.08
    ₹23.99
    downward going graph

    2.04%

    Downside

    1.83%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹15.20
    ₹55.64
    downward going graph

    35.48%

    Downside

    136.16%

    Upside

    downward going graph

Balaxi Pharmaceuticals share price movements today

Previous Close
₹23.45
Open
₹23.99
Volume
8,631.00
Upper Circuit
₹24.62
Lower Circuit
₹22.28
Day's Low - High
₹23.08 - ₹23.99
52 Week Low - High
₹15.20 - ₹55.64

Balaxi Pharmaceuticals Historical Returns

1 Month Return
-4.64 %
3 Month Return
+ 32.49 %
1 Year Return
-53.08 %
3 Year Return
-77.96 %
5 Year Return
-80.76 %

Balaxi Pharmaceuticals Fundamentals

as on June 17, 2026 at 4:01 pm IST

Market Cap

₹129.46 Cr

Return on Equity (ROE)

2.89

PE Ratio (TTM)

0

Return on capital employed (ROCE)

5.06

Beta (LTM)

1.09

P/B Ratio

2.76

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-92.94

EPS (TTM)

4.54

Book Value

41.98

Balaxi Pharmaceuticals Technical Analysis

Track how Balaxi Pharmaceuticals technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish
Bullish12
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
0.04
Bullish
CCI (20)
55.56
Neutral
RSI (14)
60.09
Neutral
Momentum (10)
0
Neutral
ADI (14)
30.38
Bullish
Ultimate Oscillator (7,14,28)
81.12
Bullish

Moving Averages

Name

Value

Action

SMA (20)
23.7
Bullish
EMA (20)
23.77
Bullish
VWMA (20)
23.78
Bullish
SMA (50)
23.76
Bullish
EMA (50)
23.74
Bullish
SMA (200)
23.7
Bullish
EMA (200)
23.72
Bullish
KAMA (200)
23.67
Bullish
DEMA (200)
23.72
Bullish

Balaxi Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Balaxi Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Balaxi Pharmaceuticals Ltd image
Balaxi Pharmaceuticals Ltd
NA129.46-16.15%0.5925292
Ishita Drugs & Industries Ltd image
Ishita Drugs & Industries Ltd
NA0.0029.25%0.00NA15
Astrazeneca Pharma India Ltd image
Astrazeneca Pharma India Ltd
NA21,257.5025.52%0.001151,716
Panjon Ltd image
Panjon Ltd
NA0.0012.11%0.00-530
Fabino Enterprises Ltd image
Fabino Enterprises Ltd
NA0.00-9.93%0.65NA18
See all

Balaxi Pharmaceuticals Stock’s Investor Sentiment and Interest

Search interest for Balaxi Pharmaceuticals Ltd Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-22% versus previous 30 day period

Balaxi Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
65.96
54.72
60.79
59.83
65.62
77.38
73.29
76.27
70.74
56.18
72.54
70.71
Other Income
-1.01
5.93
1.51
-0.7
-1.85
-4.11
3.94
-1.69
-1.78
1.59
0.1
2.92
Total Income
64.95
60.65
62.29
59.14
63.77
73.27
77.23
74.57
68.97
57.76
72.64
73.63
Expenses
103.78
43.96
47.13
46.37
55.54
66.79
69.3
63.71
66.59
55.01
69.45
70.59
Operating Profit
-37.82
10.76
13.66
13.46
10.08
10.59
3.99
12.56
4.15
1.17
3.09
0.12
Operating Profit Margin %
-57.34%
19.66%
22.47%
22.5%
15.36%
13.69%
5.44%
16.47%
5.87%
2.08%
4.26%
0.17%
Profit Before Interest, Tax and Depreciation
-38.84
16.69
15.17
12.77
8.24
6.48
7.93
10.86
2.37
2.75
3.19
3.04
Interest
0.29
0.37
0.41
0.61
0.37
0.45
1.38
0.74
1.01
0.89
1.02
0.99
Depreciation
0.29
0.66
0.48
0.67
0.49
0.46
0.48
0.46
0.46
0.48
0.56
0.65
Profit Before Tax
-39.42
15.66
14.28
11.49
7.38
5.57
6.07
9.66
0.9
1.38
1.61
1.4
Tax Paid
1.93
1.24
0.68
0.56
0.89
0.97
0.71
1.02
0.61
1.16
1.3
0.79
Profit After Tax
-41.34
14.43
13.59
10.93
6.48
4.59
5.36
8.64
0.29
0.21
0.31
0.61
Total Net profit including share of profit / Loss from associate company
-41.34
14.43
13.59
10.93
6.48
4.59
5.36
8.64
0.29
0.21
0.31
0.61
EPS
-40.49
14.1
13.29
10.41
1.17
0.84
0.97
1.56
0.05
0.04
0.06
0.11
Actual EPS
-40.49
14.1
13.29
10.41
1.17
0.84
0.97
1.56
0.05
0.04
0.06
0.11
Adjusted EPS
-8.1
2.82
2.66
2.08
1.17
0.84
0.97
1.56
0.05
0.04
0.06
0.11
Diluted EPS
-39.93
14.06
13.22
10.38
1.17
0.84
0.97
1.56
0.05
0.04
0.06
0.11

Balaxi Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
13.6
45.63
231.33
279.39
336.43
241.29
292.56
270.17
Other Income
0.81
0.59
2.23
4.97
2.64
-2.65
-3.72
2.82
Total Income
14.4
46.23
233.56
284.36
339.07
238.65
288.84
272.99
Expenses
11.96
37.44
188.92
229.18
279.89
194.56
255.35
261.65
Operating Profit
1.64
8.19
42.41
50.21
56.54
46.73
37.21
8.52
Operating Profit Margin %
12.06%
17.95%
18.33%
17.97%
16.81%
19.37%
12.72%
3.15%
Profit Before Interest, Tax and Depreciation
2.44
8.79
44.64
55.18
59.17
44.08
33.5
11.35
Interest
-
-
0.01
0.14
0.5
1.68
2.93
3.9
Depreciation
-
0.01
0.3
0.51
1.75
2.1
1.89
2.15
Profit Before Tax
2.44
8.78
44.33
54.53
56.92
40.3
28.68
5.3
Tax Paid
0.47
2.68
6.19
6.86
10.96
4.4
3.6
3.87
Profit After Tax
1.97
6.1
38.14
47.66
45.96
35.91
25.07
1.42
Total Net profit including share of profit / Loss from associate company
1.97
6.1
38.14
47.66
45.96
35.91
25.07
1.42
EPS
6.47
8.12
38.14
47.66
45.81
-2.32
4.54
0.26
Actual EPS
6.47
8.12
38.14
47.66
45.81
-2.32
4.54
0.26
Adjusted EPS
1.29
1.62
7.63
9.53
9.16
-0.46
4.54
0.26
Diluted EPS
6.47
8.12
38.14
47.66
45.4
-2.32
4.54
0.26

Balaxi Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-1.51
-14.04
-
34.14
6.08
4.87
-35
Cash Flow from Investing Activities
-0.01
-0.18
-5.98
-27.87
-8.31
-1.57
-2
Cash Flow from Financing Activities
-
18.1
3.65
-0.16
25.51
30.25
33.87
Net Cash Flow
-1.51
3.88
-2.32
5.53
21.02
34.07
-22.89

Balaxi Pharmaceuticals Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
71.22%
71.22%
66.36%
66.36%
65.99%
65.99%
65.99%
65.99%
65.99%
65.99%
65.99%
65.99%
DII
0.03%
0.03%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
2.56%
FII
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
1.74%
0%
Public
10.18%
10.18%
16.54%
16.54%
17.11%
17.5%
17.5%
17.96%
25.12%
30.49%
32.24%
31.45%
Total Outstanding Shares
1,02,30,200
1,02,30,200
1,09,80,500
1,09,80,500
5,52,07,500
5,52,07,500
5,52,07,500
5,52,07,500
5,52,07,500
5,52,07,500
5,52,07,500
5,52,07,500
Total Shareholders
5,047
5,045
5,132
5,132
6,586
7,863
8,529
9,994
13,737
14,620
15,085
15,176

Balaxi Pharmaceuticals Corporate Actions

View detailed summary of the earnings and dividend history of Balaxi Pharmaceuticals.

  • Balaxi Pharmaceuticals Ltd Earnings Results

    Balaxi Pharmaceuticals Ltd’s net profit fell -92.94% since last year same period to ₹0.61Cr in the Q4 2025-2026. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated 96.77% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Balaxi Pharmaceuticals Ltd Dividends May,2022

    In the quarter ending March 2022, Balaxi Pharmaceuticals Ltd has declared dividend of ₹0.50 per share on 23 May 2022 - translating a dividend yield of 2.13%.

    Read More about Dividends

Insights on Balaxi Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 0.21 Cr → 0.61 Cr (in ₹), with an average increase of 40.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 57.76 Cr → 73.63 Cr (in ₹), with an average increase of 10.9% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 65.99% of holdings in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, BALAXI stock has moved down by -53.1%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.74% to 0.00% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 32.24% to 31.45% in Mar 2026 quarter

About Balaxi Pharmaceuticals Ltd

Balaxi Ventures Limited formerly known as The Anandam Rubber Company, is a public limited company established in India since 1942. In 1989, the company sold its plantations to focus on investments and trading. The Securities and Exchange Board of India (SEBI) issued a revised Exit Policy in 2012 for derecognized/non-operational stock exchanges. Consequently, Madras Stock Exchange was derecognized by SEBI and The Anandam Rubber Company applied to list its shares with the National Stock Exchange of India (NSE) in January 2015.
In March 2017, Balaxi Overseas Pvt Ltd acquired 16,700,036 (54.94%) equity shares of the company along with its control and management. Its representatives became the new directors and the company was renamed to Balaxi Ventures. A preferential issue of 6,960,000 equity shares was approved in July 2019 and allotted in August, increasing the company’s paid-up share capital to Rs 100,000,000. Following this, Balaxi Ventures started international wholesale trading in pharmaceutical products, builders hardware, and recently launched YAP food products.

Revenue: ₹70.71Cr as on March 2026 (Q4 FY26)
Net Profit: ₹0.61Cr as on March 2026 (Q4 FY26)
Listing date: 30 Nov, 2015
Chairperson Name: Ashish Maheshwari
OrganisationBalaxi Pharmaceuticals Ltd
IndustryPharmaceuticals
CEOAshish Maheshwari
E-voting on sharesClick here to vote

FAQs

What is Balaxi Pharmaceuticals share price today?

Balaxi Pharmaceuticals share price today stands at ₹23.56 as on at the close of the market. Balaxi Pharmaceuticals share today touched a day high of ₹23.99 and a low of ₹23.08.

What is the 52 week high and 52 week low range for Balaxi Pharmaceuticals share?

Balaxi Pharmaceuticals touched a 52 week high of ₹55.64 and a 52 week low of ₹15.2. Balaxi Pharmaceuticals share price today i.e. is closed at ₹23.56, which is -57.66% down from its 52 week high and 55.00% up from its 52 week low.

What is Balaxi Pharmaceuticals's market capitalisation today?

Balaxi Pharmaceuticals market capitalisation is ₹129.46 Cr as on .

How to buy Balaxi Pharmaceuticals shares?

To buy Balaxi Pharmaceuticals shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for BALAXI or Balaxi Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Balaxi Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Balaxi Pharmaceuticals trading volume today?

Balaxi Pharmaceuticals trading volume is 8,631.00 as on . This means that 8,631.00 shares of Balaxi Pharmaceuticals were bought and sold on the stock market during today's trading session.